[11] This is a pathway that is both safe and evidence-based
Hepatic and gastrointestinal effects Clinical manifestations of raised copper levels in the liver due to copper sulfate poisoning comprise a wide range of signs and symptoms, including delicate and asymptomatic morphological changes in the hepatic tissue, self-limiting hepatitis-like disease to severe hepatitis, recurrent jaundice, if associated with hemolysis of red blood cells, cirrhosis, and even acute liver failure [23]
DrugPatentWatch has described this class as Advanced Drug Delivery Systems (ADDS), where a highly potent cytotoxic compound with poor aqueous solubility may be physically impossible to administer safely without nanoparticle encapsulation, and a peptide drug with a 20-minute half-life is clinically useless without a depot formulation that extends activity to weeks
The proton translocation module of complex I is composed of, at a minimum, all seven of the mtDNA encoded proteins
It's effectiveness drops off above pH 8 and it can lose potency when combined with non-ionic surfactants like polysorbate 80 due to micellization